X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale+OE | $132.96 | -1,114 | 23,716 | -4% | -$148,122 | |||||
| M | 2024-02-06 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale | $138.49 | -2,101 | 22,717 | -8% | -$290,968 | |||||
2024-01-31 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale | $140.79 | -1,457 | 20,832 | -7% | -$205,132 | ||||||
2023-12-22 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale | $126.75 | -10,000 | 19,521 | -34% | -$1,267,448 | ||||||
| D | 2023-12-12 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale+OE | $120.30 | -13,925 | 29,521 | -32% | -$1,675,240 | |||||
| DM | 2023-12-07 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale+OE | $120.37 | -77,679 | 29,521 | -72% | -$9,350,350 | |||||
| D | 2023-12-06 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale+OE | $120.03 | -8,396 | 29,521 | -22% | -$1,007,780 | |||||
2023-08-21 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale | $107.38 | -3,198 | 29,521 | -10% | -$343,388 | ||||||
2023-04-24 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale | $103.48 | -14,400 | 26,644 | -35% | -$1,490,059 | ||||||
| M | 2023-02-06 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale | $102.74 | -16,525 | 41,015 | -29% | -$1,697,707 | |||||
2023-01-31 | NBIX | Roberts Eiry | Chief Medical Officer | S - Sale | $109.99 | -1,457 | 26,171 | -5% | -$160,254 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |